Doxycycline: Difference between revisions

From IDWiki
No edit summary
mNo edit summary
 
(2 intermediate revisions by the same user not shown)
Line 1: Line 1:
== Background ==
* Tetracycline antibiotic
* Tetracycline antibiotic

=== Spectrum of Activity ===
* Can treat: {{#ask: [[Is treated by::doxycycline]]|default=none}}

=== Distribution ===

* Achieves only low concentrations in the urine, so generally not recommended for UTIs, though some debate about this[[CiteRef::jodlowski2020do]]

== Dosing ==
* Usual dosing 100 mg po BID
* Usual dosing 100 mg po BID

== Safety ==

=== Adverse Effects ===
* Counsel on high risk of sun sensitivity and pill esophagitis
* Counsel on high risk of sun sensitivity and pill esophagitis

=== Pregnancy ===
* Generally avoid using in pregnant women and children less than 8 years of age due to bone and tooth staining
* Generally avoid using in pregnant women and children less than 8 years of age due to bone and tooth staining
** However, can often tolerate short courses up to 5 days without issue
** However, can often tolerate short courses up to 5 days without issue
* Achieves only low concentrations in the urine, so generally not recommended for UTIs
* Can treat: {{#ask: [[Is treated by::doxycycline]]|default=none}}


[[Category:Tetracyclines]]
[[Category:Tetracyclines]]

Latest revision as of 17:38, 19 September 2024

Background

  • Tetracycline antibiotic

Spectrum of Activity

Distribution

  • Achieves only low concentrations in the urine, so generally not recommended for UTIs, though some debate about this1

Dosing

  • Usual dosing 100 mg po BID

Safety

Adverse Effects

  • Counsel on high risk of sun sensitivity and pill esophagitis

Pregnancy

  • Generally avoid using in pregnant women and children less than 8 years of age due to bone and tooth staining
    • However, can often tolerate short courses up to 5 days without issue

References

  1. ^  Tomasz Jodlowski, Charles R Ashby, Sarath G Nath. Doxycycline for ESBL-E Cystitis. Clinical Infectious Diseases. 2020. doi:10.1093/cid/ciaa1898.